Stage 4S neuroblastoma: What makes it special?

被引：31

作者：

Matthay, KK ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1998年 / 16卷 / 06期

关键词：

D O I：

10.1200/JCO.1998.16.6.2003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2003 / 2006

页数：4

共 41 条

[1]

[Anonymous], 34 ANN M AM SOC CLIN

[2] PHASE-I CLINICAL-TRIAL OF INTRAVENOUS L-BUTHIONINE SULFOXIMINE AND MELPHALAN - AN ATTEMPT AT MODULATION OF GLUTATHIONE [J].

BAILEY, HH ;

MULCAHY, RT ;

TUTSCH, KD ;

ARZOOMANIAN, RZ ;

ALBERTI, D ;

TOMBES, MB ;

WILDING, G ;

POMPLUN, M ;

SPRIGGS, DR .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :194-205

[3]

BLATT J, 1994, ANTICANCER RES, V14, P2109

[4] Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group Study [J].

Bowman, LC ;

Castleberry, RP ;

Cantor, A ;

Joshi, V ;

Cohn, SL ;

Smith, EI ;

Yu, A ;

Brodeur, GM ;

Hayes, FA ;

Look, AT .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :373-380

[5] REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].

BRODEUR, GM ;

PRITCHARD, J ;

BERTHOLD, F ;

CARLSEN, NLT ;

CASTEL, V ;

CASTLEBERRY, RP ;

DEBERNARDI, B ;

EVANS, AE ;

FAVROT, M ;

HEDBORG, F ;

KANEKO, M ;

KEMSHEAD, J ;

LAMPERT, F ;

LEE, REJ ;

LOOK, AT ;

PEARSON, ADJ ;

PHILIP, T ;

ROALD, B ;

SAWADA, T ;

SEEGER, RC ;

TSUCHIDA, Y ;

VOUTE, PA .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477

[6] Biology and genetics of human neuroblastomas [J].

Brodeur, GM ;

Maris, JM ;

Yamashiro, DJ ;

Hogarty, MD ;

White, PS .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (02) :93-101

[7] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].

Caron, H ;

vanSluis, P ;

deKraker, J ;

Bokkerink, J ;

Egeler, M ;

Laureys, G ;

Slater, R ;

Westerveld, A ;

Voute, PA ;

Versteeg, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230

[8] ALLELIC LOSS OF CHROMOSOME-1 AND ADDITIONAL CHROMOSOME-17 MATERIAL ARE BOTH UNFAVORABLE PROGNOSTIC MARKERS IN NEUROBLASTOMA [J].

CARON, H .

MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :215-221

[9]

Caron H, 1996, HUM GENET, V97, P834

[10]

Cheung N K, 1994, Prog Clin Biol Res, V385, P319

← 1 2 3 4 5 →